Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma

Oncolytic virus therapy leads to immunogenic death of virus-infected tumor cells and this has been shown in preclinical models to enhance the cytotoxic T-lymphocyte response against tumor-associated antigens (TAAs), leading to killing of uninfected tumor cells. To investigate whether oncolytic virot...

Descripción completa

Detalles Bibliográficos
Autores principales: Packiriswamy, Nandakumar, Upreti, Deepak, Zhou, Yumei, Khan, Rehan, Miller, Amber, Diaz, Rosa M., Rooney, Cliona M., Dispenzieri, Angela, Peng, Kah-Whye, Russell, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581629/
https://www.ncbi.nlm.nih.gov/pubmed/32327728
http://dx.doi.org/10.1038/s41375-020-0828-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581629/
https://www.ncbi.nlm.nih.gov/pubmed/32327728
http://dx.doi.org/10.1038/s41375-020-0828-7

Ejemplares similares